ALTERNATIVE DAPSONE DOSAGE REGIMEN FOR PROPHYLAXIS OF PNEUMOCYSTIS CARINII PNEUMONIA
Authors:
- Giorgio GattiGGGiorgio Gatti
- Francesca FioreddaFFFrancesca Fioredda
- Carolina LorussoCLCarolina Lorusso
- Mario CrucianiMCMario Cruciani
- Dante BassettiDBDante Bassetti
- 1 February 1996
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 15 (2) , 183-184
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Pharmacokinetics of dapsone in human immunodeficiency virus-infected childrenAntimicrobial Agents and Chemotherapy, 1995
- HIGH FAILURE RATE OF DAPSONE AND PENTAMIDINE AS PNEUMOCYSTIS CARINII PNEUMONIA PROPHYLAXIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDRENThe Pediatric Infectious Disease Journal, 1994
- Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumoniaAntimicrobial Agents and Chemotherapy, 1994
- Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitisAntimicrobial Agents and Chemotherapy, 1994
- DAPSONE PROPHYLAXIS AGAINST PNEUMOCYSTIS CARINII PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDRENThe Pediatric Infectious Disease Journal, 1994
- Pharmacokinetics of dapsone in childrenThe Journal of Pediatrics, 1993